Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jan Musiałkiewicz
Observed name:
Jan Musialkiewicz
Institution:
Poznan University of Medical Sciences
Observed institution:
Poznan University of Medical Sciences
ORCID:
0009-0002-2449-3324
Observed ORCID:
0009-0002-2449-3324
OpenAlex ID:
A5004559835
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
2022
·
Paweł Komarnicki
, Jan Musiałkiewicz
, et al.
·
Journal of Clinical Medicine
·
45
PDF
Serum β-hCG as a Biomarker in Pancreatic Neuroendocrine Tumors: Rethinking Single-Analyte Approach
2024
·
Paweł Komarnicki
, Paweł Gut
, et al.
·
Cancers
·
13
PDF
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
2023
·
Paweł Komarnicki
, Paweł Gut
, et al.
·
Endocrine Connections
·
7
PDF
Pulmonary carcinoids – analysis of early and long-term surgical treatment outcomes in a group of 90 patients
2017
·
Mariusz Kasprzyk
, Jan Musiałkiewicz
, et al.
·
Polish Journal of Cardio-Thoracic Surgery
·
7
PDF
Prevalence of Second Primary Malignancies in Patients With Well-Differentiated Neuroendocrine Tumors
2025
·
Kosma Woliński
, Paweł Komarnicki
, et al.
·
Endocrine Practice
·
4
Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours
2025
·
Jan Musiałkiewicz
, Marek Ruchała
, et al.
·
Endocrine Connections
·
3
Serum Visfatin/eNAMPT as a Biomarker in Pancreatic and Small Intestine Neuroendocrine Tumors: A Cross-Sectional Study and Future Perspectives
2025
·
Paweł Komarnicki
, Adam Maciejewski
, et al.
·
Cancers
·
3
PDF
Rapid onset Cushing's syndrome induced by the ACTH-producing pancreatic neuroendocrine tumor: a therapeutic challenge
2024
·
Paweł Komarnicki
, Jan Musiałkiewicz
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
·
2
PDF
Multiple endocrinopathies presenting simultaneously with insulinoma as the leading manifestation
2025
·
Jan Musiałkiewicz
, Paweł Komarnicki
, et al.
·
The American Journal of Medicine
·
1
Increased serum visfatin in neuroendocrine tumors shows promise as a diagnostic biomarker: a single-center, cross-sectional study
2025
·
Paweł Komarnicki
, Paweł Gut
, et al.
·
Endocrine Abstracts
·
1
The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors
2025
·
Maciej Kołodziej
, Violetta Rosiek
, et al.
·
Nuclear Medicine Review
·
1
PDF
Hyperthyroidism caused by massive toxic nodular goiter accompanied by primary hyperparathyroidism
2024
·
Jan Musiałkiewicz
, Paweł Komarnicki
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
·
1
PDF
Metabolomics in gastroenteropancreatic neuroendocrine neoplasms: a scoping review protocol
2026
·
Adam Maciejewski
, Nuttachon Khemthong
, et al.
·
Open Science Framework
Carcinoid syndrome in neuroendocrine carcinoma mimicking Clostridioides difficile sepsis
2026
·
Jan Musiałkiewicz
, Paweł Gut
, et al.
·
Endokrynologia Polska
PDF
Effective treatment of carcinoid syndrome with peptide receptor radionuclide therapy
2026
·
Jan Musiałkiewicz
, Paweł Komarnicki
, et al.
·
Endokrynologia Polska
PDF
EP912 - ECE_3058 - Multianalyte or multiple monoanalytes? A comparison of serum visfatin and chromogranin A as diagnostic biomarkers in neuroendocrine tumors
2026
·
Paweł Komarnicki
, Jan Musiałkiewicz
, et al.
·
European Journal of Endocrinology
PDF
Multidisciplinary management of severe refractory hypoglycemia
2026
·
Alicja Rajewska
, Paweł Komarnicki
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
PDF
Prognostic and Predictive Significance of Selected Gene Mutations in Pancreatic and Intestinal Neuroendocrine Tumors
2026
·
Jan Musiałkiewicz
, Bartłomiej Budny
, et al.
·
International Journal of Molecular Sciences
Prevalence of adrenal incidentalomas in patients with neuroendocrine tumours
2024
·
Adam Maciejewski
, Paweł Komarnicki
, et al.
·
Endocrine Abstracts
Bone mineral density in patients suffering from Turner syndrome. The role of hormonal replacement therapy
2019
·
Anna Szeliga
, Agnieszka Podfigurna
, et al.
·
Maturitas
Show more works
View as search
Works count:
20
Citation count:
88
H-index:
4
I10-index:
2
Year
Topic
Type